A.C. PHARMA
ActiveSummary
The annual accounts of A.C. PHARMA for financial year 2025 show a net loss of 63% of the equity at the start of that year. The 2025 annual accounts show equity of €43,466 and a net result of -€74,212. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 27% of 12,678 sector peers (NACE 47, financial year 2025). The company has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.4% (low).
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 25 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21302A0534/00X007 | Brussels | 87 m² | 1 · 82 m² | 19.1 m · 6 |